Mayree C. Clark
CIK: 0001603757
Associated companies
Transaction History
| ALLY | ▲ Buy | Grant | 3,632 | $153K | 5/15/2026 | View on chart |
| ALLY | ▲ Buy | Grant | 4,266 | $153K | 5/15/2025 | View on chart |
| ALLY | ▲ Buy | Grant | 3,528 | $145K | 5/15/2024 | View on chart |
| ALLY | ▲ Buy | Grant | 466 | $0 | 1/5/2024 | View on chart |
| ALLY | ▲ Buy | Grant | 610 | $0 | 10/6/2023 | View on chart |
| ALLY | ▲ Buy | Grant | 602 | $0 | 7/6/2023 | View on chart |
| ALLY | ▲ Buy | Grant | 5,673 | $145K | 5/15/2023 | View on chart |
| ALLY | ▲ Buy | Grant | 638 | $0 | 4/7/2023 | View on chart |
| ALLY | ▲ Buy | Grant | 3,664 | $145K | 5/13/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Wells Fargo Downgrades Ally Financial to Equal-Weight
Wells Fargo downgraded Ally Financial to Equal-Weight and lowered its price target to $42. This action stands out against a broader analyst consensus that currently averages a $51.95 target. The stock is trading near its 52-week low, reflecting recent market pressure despite a valuation that some analysts view as undervalued.
Wells Fargo Downgrades Ally Financial to Equal-Weight. Wells Fargo downgraded Ally Financial to Equal-Weight and lowered its price target to $42. This action stands out against a broader analyst consensus that currently averages a $51.95 target. The stock is trading near its 52-week low, reflecting recent market pressure despite a valuation that some analysts view as undervalued.